Information and resources for healthcare professionals
Patients implanted with a CyPass® Micro-Stent are encouraged to contact their eye doctor to schedule an in-office evaluation. Media inquiries should be directed to Steven Smith at +1 817 551 8211 or [email protected].
Information from Alcon
ESCRS Scientific Presentation / Sept. 24, 2018 Overview of the results from the 5 year follow up study of the CyPass® Micro-Stent Read More
Dear Healthcare Professional Letter / Aug. 29, 2018 Voluntary Medical Device Market Withdrawal Notification Read More
Alcon Media Release / Aug. 29, 2018 Alcon announces voluntary global market withdrawal of CyPass® Micro-Stent for surgical glaucoma Read More
Product Information CyPass® Ultra System Instructions for Use Read More
Product Information CyPass® Micro-Stent Instructions for Use Read More
The following information has been published by other professional and regulatory organizations, and is provided as a service to healthcare professionals. Alcon assumes no responsibility for the information provided by these independent organizations.
FDA Safety Communication / Oct. 24, 2018 UPDATE: Potential Eye Damage from Alcon CyPass Micro-Stent Used to Treat Open-Angle Glaucoma: FDA Safety Communication Read More